Cargando…
En route to Peptide Therapeutics for COVID 19: Harnessing Potential Antigenic Mimicry Between Viral and Human Proteins
Molecular mimicry is a general strategy used by pathogens to infect the host cells. The emergence of SARS-CoV-2 virus has resulted in more than 6,700,000 infections and 390,000 deaths worldwide. Coronavirus disease (COVID-19) is an infectious disease caused by this virus. In this project concept, we...
Autores principales: | Madhavan, Maya, Mustafa, Sabeena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306100/ http://dx.doi.org/10.1007/s41403-020-00132-8 |
Ejemplares similares
-
Exploring peptide studies related to SARS-CoV to accelerate the development of novel therapeutic and prophylactic solutions against COVID-19
por: Madhavan, Maya, et al.
Publicado: (2021) -
COVID-19: Need for Equitable and Inclusive Pandemic Response Framework
por: Mustafa, Sabeena, et al.
Publicado: (2020) -
Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review
por: Mustafa, Sabeena, et al.
Publicado: (2018) -
Viral apoptotic mimicry
por: Amara, Ali, et al.
Publicado: (2015) -
Peptide-Protein Interaction Studies of Antimicrobial Peptides Targeting Middle East Respiratory Syndrome Coronavirus Spike Protein: An In Silico Approach
por: Mustafa, Sabeena, et al.
Publicado: (2019)